← Leaderboards
Laura Pasqualucci
Columbia University Health Sciences
$5,549,983
Attributed
$5,806,646
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $852.1K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,806,646 · 3
By mechanism
R01$5,421,652 · 2
R21$384,994 · 1
Top collaborators
- Raul Rabadan2 shared
- Pascale Willem2 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Joseph Hyungwoo Lee$11,176,176
- Jonathan M. Barasch$18,196,986
- Christiane Reitz$17,861,730
- Lorraine N Clark$7,054,136
- Angela M Christiano$35,497,344
Others in their field
Top investigators on “S Lymphoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$171,980,034
- Richard L Schilsky · University Of Chicago$120,036,663
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$113,682,224
- Ronald T Mitsuyasu · University Of California Los Angeles$103,553,444
- Monica M Bertagnolli · Strang Cancer Prevention Center$61,393,123
- Charles A Coltman · Southwest Oncology Group$55,198,633
Research focus
S LymphomaDiagnosisAccountingGeneticTranscriptome SequencingLymphomaFollicular LymphomaPathogenesisDiagnosticMolecularLesionTumorLarge Cell Diffuse Non-Hodgkin&AposMutationMalignant NeoplasmsIn VivoDosageInsightB-LymphocytesMouse StrainsAffectBcl2 GeneMaintenanceMouse Model
Grant awards (16)
Role of CREBBP missense mutations in lymphomagenesis$475,089
R01 · FY2025 · CA · contact PI
Role of CREBBP missense mutations in lymphomagenesis$451,334
R01 · FY2024 · CA · contact PI
Role of CREBBP missense mutations in lymphomagenesis$465,588
R01 · FY2023 · CA · contact PI
Role of CREBBP missense mutations in lymphomagenesis$475,089
R01 · FY2022 · CA · contact PI
Role of KMT2D Gene Inactivation in B cell Non Hodgkin Lymphoma$377,055
R01 · FY2022 · CA · contact PI
Role of KMT2D Gene Inactivation in B cell Non Hodgkin Lymphoma$384,750
R01 · FY2021 · CA · contact PI
Role of KMT2D Gene Inactivation in B cell Non Hodgkin Lymphoma$384,750
R01 · FY2020 · CA · contact PI
Role of KMT2D Gene Inactivation in B cell Non Hodgkin Lymphoma$373,207
R01 · FY2019 · CA · contact PI
Role of KMT2D Gene Inactivation in B cell Non Hodgkin Lymphoma$384,750
R01 · FY2018 · CA · contact PI
Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma$332,000
R01 · FY2017 · CA · contact PI
Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma$332,000
R01 · FY2016 · CA · contact PI
The coding genome of HIV-associated plasmablastic lymphomas in South Africa$187,475
R21 · FY2016 · CA
Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma$332,000
R01 · FY2015 · CA · contact PI
The coding genome of HIV-associated plasmablastic lymphomas in South Africa$197,519
R21 · FY2015 · CA
Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma$322,040
R01 · FY2014 · CA · contact PI
Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma$332,000
R01 · FY2013 · CA · contact PI